文献速递急性肾损伤

肥大细胞糜蛋白酶通过限制中性粒细胞过度激活和募集减轻急性缺血性肾损伤

Mast cell chymase protects against acute ischemic kidney injury by limiting neutrophil hyperactivation and recruitment.
PubMed 文献 · Kidney Int · 2019-10-10

该研究在小鼠肾缺血再灌注损伤模型中探讨肥大细胞蛋白酶4(MCPT4,人类肥大细胞糜蛋白酶的功能对应物)的作用。MCPT4缺陷小鼠肾功能恶化,肾脏中性粒细胞浸润、髓过氧化物酶表达、细胞死亡和坏死增加。体外实验显示人类糜蛋白酶可切割中性粒细胞CD162及内皮细胞CD54、P-选择素和E-选择素。MCPT4还抑制全身中性粒细胞激活。结论:MCPT4糜蛋白酶在肾缺血再灌注损伤中发挥抗炎作用,通过控制中性粒细胞外渗和激活限制损伤。

要点

  • MCPT4缺陷加重肾缺血再灌注损伤后的肾功能恶化和病理损伤。
  • MCPT4通过切割黏附分子CD162、CD54、P-选择素和E-选择素限制中性粒细胞外渗。
  • MCPT4抑制全身中性粒细胞激活,减少CD11b表达和活性氧产生。

核心结论

  • MCPT4糜蛋白酶在肾缺血再灌注损伤中通过控制中性粒细胞外渗和激活发挥抗炎保护作用。

研究设计与样本

  • 小鼠肾缺血再灌注损伤模型,比较MCPT4缺陷小鼠与野生型小鼠。

主要发现

  • MCPT4缺陷小鼠肾功能较野生型恶化。
  • MCPT4缺陷小鼠肾脏中性粒细胞浸润、髓过氧化物酶表达、细胞死亡和坏死增加。
  • MCPT4缺陷小鼠肾脏中性粒细胞CD162和内皮细胞CD54表面表达增加。
  • 体外人类糜蛋白酶切割中性粒细胞CD162及内皮细胞CD54、P-选择素和E-选择素。
  • MCPT4缺陷小鼠中性粒细胞CD11b表达和活性氧产生增加,远端炎症部位中性粒细胞迁移增加。

临床怎么用

  • 提示肥大细胞糜蛋白酶通路可能为急性缺血性肾损伤提供抗炎治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Here we investigated the role of murine mast cell protease 4 (MCPT4), the functional counterpart of human mast cell chymase, in an experimental model of renal ischemia reperfusion injury, a major cause of acute kidney injury. MCPT4-deficient mice had worsened kidney function compared to wildtype mice. MCPT4 absence exacerbated pathologic neutrophil infiltration in the kidney and increased kidney myeloperoxidase expression, cell death and necrosis. In kidneys with ischemia reperfusion injury, when compared to wildtype mice, MCPT4-deficient mice showed increased surface expression of adhesion molecules necessary for leukocyte extravasation including neutrophil CD162 and endothelial cell CD54. In vitro, human chymase mediated the cleavage of neutrophil expressed CD162 and also CD54, P- and E-Selectin expressed on human glomerular endothelial cells. MCPT4 also dampened systemic neutrophil activation after renal ischemia reperfusion injury as neutrophils expressed more CD11b integrin and produced more reactive oxygen species in MCPT4-deficient mice. Accordingly, after renal injury, neutrophil migration to an inflammatory site distal from the kidney was increased in MCPT4-deficient versus wildtype mice. Thus, contrary to the described overall aggravating role of mast cells, one granule-released mediator, the MCPT4 chymase, exhibits a potent anti-inflammatory function in renal ischemia reperfusion injury by controlling neutrophil extravasation and activation thereby limiting associated damage.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Madjene LC, Danelli L, Dahdah A, et al. Mast cell chymase protects against acute ischemic kidney injury by limiting neutrophil hyperactivation and recruitment. Kidney Int. 2019. PMID: 31866111. doi:10.1016/j.kint.2019.08.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。